Source:Hearing Research
Author(s): Lawrence R. Lustig
from #Audiology via ola Kala on Inoreader https://ift.tt/2rAjCPI
via IFTTT
OtoRhinoLaryngology by Sfakianakis G.Alexandros Sfakianakis G.Alexandros,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,tel : 00302841026182,00306932607174
MED-EL (http://www.medel.com/us/) has received FDA clearance for its new non-surgical bone conduction hearing device ADHEAR, designed for those with conductive hearing loss and single-sided hearing loss. To use ADHEAR, a patented adhesive adapter is placed onto the skin behind the ear, and is worn for three to seven days at a time. The lightweight audio processor can be clicked on and off the adapter each day. It picks up sound waves, converts them into vibrations and transmits them onto the bone via the adhesive adaptor. The bone then transfers the vibrations through the skull to the inner ear, where they are processed as normal sounds. ADHEAR comfortably stays in position without applying pressure onto the skin. MED-EL acquired the device’s technology from the Swedish medical device company Otorix in 2016 and further developed it. The company anticipates that ADHEAR will be available in the summer of 2018, and will provide training for hearing health professionals throughout the country.
MED-EL (http://www.medel.com/us/) has received FDA clearance for its new non-surgical bone conduction hearing device ADHEAR, designed for those with conductive hearing loss and single-sided hearing loss. To use ADHEAR, a patented adhesive adapter is placed onto the skin behind the ear, and is worn for three to seven days at a time. The lightweight audio processor can be clicked on and off the adapter each day. It picks up sound waves, converts them into vibrations and transmits them onto the bone via the adhesive adaptor. The bone then transfers the vibrations through the skull to the inner ear, where they are processed as normal sounds. ADHEAR comfortably stays in position without applying pressure onto the skin. MED-EL acquired the device’s technology from the Swedish medical device company Otorix in 2016 and further developed it. The company anticipates that ADHEAR will be available in the summer of 2018, and will provide training for hearing health professionals throughout the country.
MED-EL (http://www.medel.com/us/) has received FDA clearance for its new non-surgical bone conduction hearing device ADHEAR, designed for those with conductive hearing loss and single-sided hearing loss. To use ADHEAR, a patented adhesive adapter is placed onto the skin behind the ear, and is worn for three to seven days at a time. The lightweight audio processor can be clicked on and off the adapter each day. It picks up sound waves, converts them into vibrations and transmits them onto the bone via the adhesive adaptor. The bone then transfers the vibrations through the skull to the inner ear, where they are processed as normal sounds. ADHEAR comfortably stays in position without applying pressure onto the skin. MED-EL acquired the device’s technology from the Swedish medical device company Otorix in 2016 and further developed it. The company anticipates that ADHEAR will be available in the summer of 2018, and will provide training for hearing health professionals throughout the country.
Diane GuerreroThe SDSU chapter of NSSLHA earned Gold Chapter Honors from the National NSSLHA Executive Council! SDSU’s chapter is recognized for:
SLHS Master’s student Diane Guerrero earned the NSSLHA Member Honors – Excellence Award (SLP) for her outstanding accomplishments. To celebrate her efforts, she will be:
Congratulations to all!
Diane GuerreroThe SDSU chapter of NSSLHA earned Gold Chapter Honors from the National NSSLHA Executive Council! SDSU’s chapter is recognized for:
SLHS Master’s student Diane Guerrero earned the NSSLHA Member Honors – Excellence Award (SLP) for her outstanding accomplishments. To celebrate her efforts, she will be:
Congratulations to all!
Diane GuerreroThe SDSU chapter of NSSLHA earned Gold Chapter Honors from the National NSSLHA Executive Council! SDSU’s chapter is recognized for:
SLHS Master’s student Diane Guerrero earned the NSSLHA Member Honors – Excellence Award (SLP) for her outstanding accomplishments. To celebrate her efforts, she will be:
Congratulations to all!
Chronic lead exposure induces cochlear oxidative stress and potentiates noise-induced hearing loss.
Toxicol Lett. 2018 May 07;:
Authors: Jamesdaniel S, Rosati R, Westrick J, Ruden DM
Abstract
Acquired hearing loss is caused by complex interactions of multiple environmental risk factors, such as elevated levels of lead and noise, which are prevalent in urban communities. This study delineates the mechanism underlying lead-induced auditory dysfunction and its potential interaction with noise exposure. Young-adult C57BL/6 mice were exposed to: 1) control conditions; 2) 2 mM lead acetate in drinking water for 28 days; 3) 90 dB broadband noise 2 h/day for two weeks; and 4) both lead and noise. Blood lead levels were measured by inductively coupled plasma mass spectrometry analysis (ICP-MS) lead-induced cochlear oxidative stress signaling was assessed using targeted gene arrays, and the hearing thresholds were assessed by recording auditory brainstem responses. Chronic lead exposure downregulated cochlear Sod1, Gpx1, and Gstk1, which encode critical antioxidant enzymes, and upregulated ApoE, Hspa1a, Ercc2, Prnp, Ccl5, and Sqstm1, which are indicative of cellular apoptosis. Isolated exposure to lead or noise induced 8-12 dB and 11-25 dB shifts in hearing thresholds, respectively. Combined exposure induced 18-30 dB shifts, which was significantly higher than that observed with isolated exposures. This study suggests that chronic exposure to lead induces cochlear oxidative stress and potentiates noise-induced hearing impairment, possibly through parallel pathways.
PMID: 29746905 [PubMed - as supplied by publisher]